首页> 外国专利> TRIAZOLOQUINAZOLINE AND PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES, MEDICINAL COMPOSITIONS, ADENOSINE A3 RECEPTOR AFFINITY AGENTS, OCULAR TENSION LOWERING AGENTS, PREPARATIONS FOR PREVENTING AND TREATING GLAUCOMA AND METHOD OF LOWERING OCULAR TENSION

TRIAZOLOQUINAZOLINE AND PYRAZOLOTRIAZOLOPYRIMIDINE DERIVATIVES, MEDICINAL COMPOSITIONS, ADENOSINE A3 RECEPTOR AFFINITY AGENTS, OCULAR TENSION LOWERING AGENTS, PREPARATIONS FOR PREVENTING AND TREATING GLAUCOMA AND METHOD OF LOWERING OCULAR TENSION

机译:噻唑并喹唑啉和吡唑并三唑并嘧啶衍生物,药物成分,腺苷A3受体亲和力剂,眼张力降落剂,预防和治疗青光眼的制备方法以及降低眼球张力的方法

摘要

The present invention provides triazoloquinazoline and pyrazolotriazolopyrimidine derivatives represented by the following general formula (1): CHEM wherein R1 and R2 represent the same groups as those described in the description; and A represents a pyrazole or benzene ring which is optionally substituted with the groups described in the description. These derivatives exhibit an affinity to an adenosine A3 receptor and also have an intraocular-pressure reducing effect, and are useful for prevention or treatment of glaucoma.
机译:本发明提供由以下通式(1)表示的三唑并喹唑啉和吡唑并三唑并嘧啶衍生物:& CHEM&其中R 1和R 2表示与说明书中所述相同的基团。 A表示吡唑或苯环,其任选被说明书中所述的基团取代。这些衍生物表现出对腺苷A3受体的亲和力,还具有降低眼内压的作用,可用于预防或治疗青光眼。

著录项

  • 公开/公告号EP1364953A4

    专利类型

  • 公开/公告日2004-06-09

    原文格式PDF

  • 申请/专利权人 OTSUKA PHARMACEUTICAL FACTORY INC.;

    申请/专利号EP20020711292

  • 申请日2002-02-01

  • 分类号C07D487/14;C07D487/04;A61K31/519;A61P43/00;A61P27/06;A61P9/12;A61P37/08;A61P29/00;A61P9/10;A61P35/02;A61P17/04;A61P11/10;A61P11/14;A61P11/06;

  • 国家 EP

  • 入库时间 2022-08-21 22:54:22

相似文献

  • 专利
  • 外文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号